# US 8,278,075 B2 · L-cysteine-producing bacterium and a method for producing L-cysteine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,075 B2
- Document ID: US8278075B2
- Status: Granted
- Kind: B2
- Application number: 12/858,590
- Filed: 2010-08-18
- Published: 2011-02-10
- Granted: 2012-10-02
- Earliest claimed: 2008-02-21
- Assignees: Ajinomoto Co., Inc.; National University Corporation Nara Institute of Science and Technology
- Inventors: Gen Nonaka; Hiroshi Takagi; Iwao Ohtsu
- Web page: https://patentgrep.com/patent/US8278075B2

## CPC

- C12N 1/20: Bacteria; Culture media therefor
- C07K 14/245: Escherichia (G)
- C12P 13/12: Methionine; Cysteine; Cystine
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

L-Cysteine, L-cystine, a derivative or precursor thereof, or a mixture thereof is produced by culturing a bacterium belonging to the family Enterobacteriaceae, which has L-cysteine-producing ability and has been modified so that the activity of a protein encoded by a tolC gene, for example, a protein defined in the following (a) or (b), is increased in a medium, and by collecting L-cysteine, L-cystine, a derivative or precursor thereof, or a mixture thereof from the medium: (a) a protein comprising the amino acid sequence of SEQ ID NO: 2, (b) a protein comprising the amino acid sequence of SEQ ID NO: 2, but wherein one or several amino acid residues are substituted, deleted, inserted or added, increase of which activity in the bacterium improves the ability of the bacterium to produce L-cysteine.

## Claims

### Claim 1

A method for producing L-cysteine, L-cystine, a derivative or precursor thereof, or a mixture thereof, which comprises culturing a bacterium belonging to the family Enterobacteriaceae in a medium and collecting L-cysteine, L-cystine, a derivative or precursor thereof, or a mixture thereof from the medium, wherein the bacterium has the ability to produce L-cysteine and has been modified so that an activity of a protein encoded by a tolC gene is increased as compared to a non-modified bacterium,
wherein the activity of the protein is increased by increasing expression amount of the tolC gene, increasing translation amount of the tolC gene, or combinations thereof.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the derivative of L-cysteine is a thiazolidine derivative.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the precursor of L-cysteine is O-acetylserine or N-acetylserine.

### Claim 4 (depends on 1)

The method according to claim 1, wherein expression amount of the tolC gene is increased by increasing a copy number of the tolC gene, or by modifying an expression control sequence of the gene.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the protein is selected from the group consisting of:
(a) a protein comprising the amino acid sequence of SEQ ID NO: 2, and
(b) a protein comprising the amino acid sequence of SEQ ID NO: 2, but wherein one to five amino acid residues are substituted, deleted, inserted or added, wherein the increase of the activity in the bacterium improves the ability of the bacterium to produce L-cysteine.

### Claim 6 (depends on 1)

The method according to claim 1, wherein the tolC gene is selected from a group consisting of:
(a) a DNA comprising the nucleotide sequence of SEQ ID NO: 1,
(b) a DNA which hybridizes with the nucleotide sequence of SEQ ID NO: 1, or a probe prepared from the nucleotide sequence, under stringent conditions comprising washing at 60° C. at a salt concentration of 0.1×SSC and 0.1% SDS, and codes for a protein, wherein the increase of the activity in the bacterium improves the ability of the bacterium to produce L-cysteine.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the bacterium contains a mutant serine acetyltransferase in which feedback inhibition by L-cysteine has been attenuated.

### Claim 8 (depends on 1)

The method according to claim 1, wherein the bacterium has increased activity of the protein encoded by a ydeD gene.

### Claim 9 (depends on 1)

The method according to claim 1, wherein the bacterium has decreased activity of a protein having cysteine desulfhydrase activity.

### Claim 10 (depends on 7)

The method according to claim 7, wherein the bacterium has increased activity of the protein encoded by a ydeD gene.

### Claim 11 (depends on 7)

The method according to claim 7, wherein the bacterium has decreased activity of a protein having cysteine desulfhydrase activity.

### Claim 12 (depends on 8)

The method according to claim 8, wherein the bacterium has decreased activity of a protein having cysteine desulfhydrase activity.

### Claim 13 (depends on 10)

The method according to claim 10, wherein the bacterium has decreased activity of a protein having cysteine desulfhydrase activity.

### Claim 14 (depends on 9)

The method according to claim 9, wherein the protein having the cysteine desulfhydrase activity is tryptophanase.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the bacterium is an Escherichia bacterium.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the bacterium is Escherichia coli.
